Clinical study of Unani drugs in the treatment of warts

Single-Blind Randomized Clinical Trial of Test Unani Drugs in the Treatment of Thaalil (Warts) - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/10/096432

Enrollment

Registered

2025-10-23

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: Test drug- Zangar(Verdigris) and Sirka (Vinegar): Zimad of Zangar(Verdigris) with Sirka (Vinegar) applied twice daily for 3 weeks Control Intervention1: Comprarator Drug Haratal(Arsenic

Eligibility

Inclusion criteria

Inclusion criteria: 1.Includes all gender with age 03 year (School going children) and above. 2.Clinically diagnosed patient of thalil. 3.Patient willing to sign the written informed consent.

Exclusion criteria

Exclusion criteria: All gender patients below 03 years Non cases of other concomitant skin diseases Patients with genital warts Pregnant and lactating females Patient who did not willing to sign the return informed consent and remain absent during the study

Design outcomes

Primary

Measure	Time frame
Improvement in sign and symptoms and Lesion of WartsTimepoint: Baseline, 1 week, 2 weeks, 3 weeks	—

Secondary

Measure	Time frame
Changes in the condition on the basis of photographsTimepoint: 0, 7th, 14th and 21st day	—

Countries

India

Contacts

Public ContactDanish Irfan

Ajmal Khan Tibbiya College AMU Aligarh

drzamiramrohi@gmail.com8475007594

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026